Chronic Bronchitis, COPD, Pneumonia
Conditions
Keywords
quality of care, antibiotic use, intervention, lower respiratory tract infections, Community acquired Pneumonia, Acute Exacerbation of Chronic Bronchitis or COPD
Brief summary
The purpose of this study is to test a strategy to improve the quality of antibiotic use in lower respiratory tract infections (LRTIs) at hospitals. Therefore, a multifaceted intervention strategy is compared to a control strategy and the effectiveness and feasibility of the intervention is assessed.
Detailed description
Improving processes of care in patients with hospital LRTI has been related to better patient outcome. Inappropriate use of antibiotics has contributed to the emergence and spread of drug-resistant micro organisms and increased treatment costs. International guidelines provide recommendations for the initial evaluation and management of LRTI, including advice on judicious antibiotic therapy. Nonetheless, studies have demonstrated a wide variability in adherence to these guidelines. To implement key recommendations in clinical practice, various strategies have been used, with mixed results. Perhaps the most important aspect of choosing a potentially effective intervention is that the choice of intervention should be based upon assessment of potential barriers in the target group. Many intervention studies are flawed by failing to control for secular trends. The investigators performed a cluster randomised controlled trial, to study the effect of a multifaceted intervention strategy on the quality of antibiotic use for LRTI. Their intervention was tailored to the areas most in need for improvement and took perceived barriers in the target group into consideration at the individual hospital level.
Interventions
BEHAVIORALProfessional audit and feedback
BEHAVIORALProcess analysis and redesign
BEHAVIORALProfessional education
BEHAVIORALImplementation of a Critical Care Pathway
Sponsors
Radboud University Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
ECT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients admitted to a respiratory care or internal medicine ward with community-acquired pneumonia or acute exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (COPD)
Exclusion criteria
* Recent (\< 30 days) admission for LRTI * Patients with underlying immunodeficiency (HIV infection, neutropenia, treatment with immunomodulating drugs, active hematological malignancies, anatomical or functional asplenia and hypogammaglobulinemia) * Patients already on treatment with antibiotics for another culture proven infection at the time of admission * Patients from nursing homes * Patients who had been transferred to another hospital or ICU and patients who had died within 24 hours of admission * Patients with very poor prognosis (life expectancy \< 2 weeks on admission).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| adherence to key quality indicators for antibiotic use in lower respiratory tract infections (indicators were developed from current [inter]national guideline recommendations and a systematic review of the literature) | — |
Secondary
| Measure | Time frame |
|---|---|
| process evaluation: how well was the intervention performed | — |
| length of hospital stay | — |
| cost | — |
| Intensive Care Unit (ICU)-transfer | — |
| 30 day re-admission rate | — |
| in-hospital mortality | — |
Countries
Netherlands
Outcome results
None listed